Haller, Michael J, et al. “Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data”. 2019. Diabetes, vol. 68, no. 6, 2019, pp. 1267–1276.